SCHEMBL2069322

SCHEMBL2069322

Cc1ccc(S(=O)(=O)Nc2ccc3ccccc3c2-c2c(NS(=O)(=O)c3ccc(C)cc3)ccc3ccccc23)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.71
NFE2L2 Q16236 1/20 0.71
HSP90AA1 P07900 1/20 0.69
CRHBP P24387 1/20 0.69
CRHR2 Q13324 1/20 0.69
HKDC1 Q2TB90 1/20 0.63
EP300 Q09472 1/20 0.61
KAT2B Q92831 1/20 0.61
KAT8 Q9H7Z6 1/20 0.61
LMNA P02545 3/20 0.58
CYP2C9 P11712 2/20 0.58
CYP2C19 P33261 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
USP2 O75604 1/20 0.58
POLB P06746 1/20 0.58
NOD2 Q9HC29 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2068293 0.92 HKDC1 (0.70) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL30238204 0.92 KEAP1 (0.61) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL6295723 0.85 CHEK1 (0.75) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL7573136 0.84 KEAP1 (0.76) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL18870843 0.84 HKDC1 (0.67) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL31238776 0.84 HSP90AA1 (0.55) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL30620530 0.84 ALDH1A1 (0.65) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL3984291 0.82 METAP2 (0.82) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL9178476 0.80 LMNA (0.73) KEAP1NFE2L2EP300KAT2BKAT8
SCHEMBL7571483 0.79 LMNA (0.67) KEAP1NFE2L2HSP90AA1CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902207-B2 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-03-08 US disclosed
US-20070142639-A1 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142639-A1 Process for production of amines SMS, CCNT1, PEAK1 KEAP1 1733/4885NFE2L2 1195/4885HSP90AA1 3361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.